Stanozolol as a novel therapeutic agent in dermatology
Open Access
- 31 August 1995
- journal article
- review article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 33 (2), 254-258
- https://doi.org/10.1016/0190-9622(95)90244-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The clinical spectrum of lipodermatosclerosisJournal of the American Academy of Dermatology, 1993
- Stanozolol causes rapid pain relief and healing of cutaneous ulcers caused by cryofibrinogenemiaJournal of the American Academy of Dermatology, 1993
- Liver pathology associated with the use of anabolic‐androgenic steroidsLiver International, 1992
- EFFICACY OF FIBRINOLYTlC ENHANCEMENT WITH STANOZOLOL IN THE TREATMENT OF VENOUS INSUFFICIENCYAnz Journal of Surgery, 1991
- A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis.Annals Of The Rheumatic Diseases, 1991
- Transcutaneous oxygen tensions in assessing the treatment of healed venous ulcersBritish Journal of Surgery, 1990
- The effect of the anabolic steroid, stanozolol, on the production of procollagenase by human synovial and skin fibroblastsin vitroInflammation Research, 1989
- Clinical parameters and transcutaneous oxygen measurements for the prognosis of venous ulcersJournal of the American Academy of Dermatology, 1989
- Treatment of liposclerosis of the leg by fibrinolytic enhancement: a preliminary report.BMJ, 1977
- STEROIDAL [3,2-c]PYRAZOLESJournal of the American Chemical Society, 1959